http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2198641-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f65792427633a2be175feb6ec0ff75e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 |
| filingDate | 1999-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae42ef4f34edd2bc00fa13f3e69ad085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b43971fb2d454c74a048ef9f0b10538 |
| publicationDate | 2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2198641-C2 |
| titleOfInvention | Method for treating ophthalmic diseases |
| abstract | FIELD: medicine. SUBSTANCE: method involves applying treatment to an eye as combination of laser radiation therapy - laser stimulation or laser coagulation and Dalargin solution injections under conjunctiva three days later after finishing laser therapy. Retina and optic nerve disk being injured, Dalargin is parabulbary administered. Dalargin injections are done as 0.1% solution at a dose of 0.3-0.7 ml during 15 days. EFFECT: accelerated treatment course and social rehabilitation of patients. 4 cl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211006-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-038010-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008091177-A1 |
| priorityDate | 1999-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.